Y Trademark

Trademark Overview

On Monday, July 19, 2021, a trademark application was filed for Y with the United States Patent and Trademark Office. The USPTO has given the Y trademark a serial number of 90836124. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 18, 2025. This trademark is owned by Cytovia Therapeutics, Inc.. The Y trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in natural killer cell therapies

Research and development in the field of immunotherapy; research and development in the field of cancer treatment; research and development in the field of natural killer cells
y

General Information

Serial Number90836124
Word MarkY
Filing DateMonday, July 19, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 17, 2022

Trademark Statements

Description of MarkThe mark consists of a polygon with a "Y" design in the center.
Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in natural killer cell therapies
Goods and ServicesResearch and development in the field of immunotherapy; research and development in the field of cancer treatment; research and development in the field of natural killer cells

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytovia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAventura, FL 33180
Party NameCytovia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAventura, FL 33180

Trademark Events

Event DateEvent Description
Wednesday, April 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 17, 2022PUBLISHED FOR OPPOSITION
Thursday, July 22, 2021NEW APPLICATION ENTERED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 22, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 11, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 12, 2023SOU EXTENSION 1 FILED
Thursday, January 12, 2023SOU EXTENSION 1 GRANTED
Wednesday, January 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023SOU EXTENSION 2 FILED
Saturday, January 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2023SOU EXTENSION 2 GRANTED
Thursday, July 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 11, 2024SOU EXTENSION 3 FILED
Thursday, January 11, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 4 GRANTED
Wednesday, July 10, 2024SOU EXTENSION 4 FILED
Wednesday, January 8, 2025SOU EXTENSION 5 FILED
Wednesday, January 8, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 14, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 29, 2025SOU EXTENSION 5 GRANTED
Wednesday, April 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 16, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, May 16, 2025WITHDRAWAL OF ATTORNEY GRANTED
Monday, August 18, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, August 18, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

research development field preparations pharmaceutical killer cancer treatment natural immunotherapy